Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity

SIMPLE SUMMARY: The residual cancer burden (RCB) score provides prognostic information on the survival of breast cancer patients who underwent neoadjuvant systemic therapy, with the greatest impact of higher scores on worse recurrence-free survival (RFS) and overall survival (OS) in triple-negative...

Descripción completa

Detalles Bibliográficos
Autores principales: Suppan, Christoph, Posch, Florian, Mueller, Hannah Deborah, Mischitz, Nina, Steiner, Daniel, Klocker, Eva Valentina, Setaffy, Lisa, Bargfrieder, Ute, Hammer, Robert, Hauser, Hubert, Jost, Philipp J., Dandachi, Nadia, Lax, Sigurd, Balic, Marija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161089/
https://www.ncbi.nlm.nih.gov/pubmed/34065332
http://dx.doi.org/10.3390/cancers13102492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161089/
https://www.ncbi.nlm.nih.gov/pubmed/34065332
http://dx.doi.org/10.3390/cancers13102492

Ejemplares similares